Market revenue in 2023 | USD 230.5 million |
Market revenue in 2030 | USD 329.0 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.54% in 2023. Horizon Databook has segmented the France point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
This market is projected to exhibit a lucrative CAGR during the forecast period, owing to an increase in the prevalence of chronic diseases, technological advancements, and awareness about molecular diagnostics. In addition, France has one of the highest incidences of cancer globally. According to WHO, in 2020, around 467 thousand new cancer cases were diagnosed in France.
Cancer incidence is expected to increase to approximately 531 thousand by 2030, constituting one of the key factors driving market growth. Research activities pertaining to early diagnosis are increasing the demand for molecular diagnostics. In addition, the presence of key manufacturers such as bioMérieux SA and the growth in strategic initiatives undertaken by them can make a positive impact on the French market.
Horizon Databook provides a detailed overview of country-level data and insights on the France point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into France point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account